Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.25.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XADENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XABENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XALENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.10.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.99ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.343ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.17 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.25.1.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.409ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.310ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.362.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.162ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Y.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.154ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.137ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.446ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.76 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.398ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.163ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.3 (Theta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used